| Literature DB >> 30567752 |
Rabea Wagener1,2, Julian Seufert3,4, Francesco Raimondi5, Susanne Bens1,2, Kortine Kleinheinz6,7, Inga Nagel2,8, Janine Altmüller9, Holger Thiele10, Daniel Hübschmann7,11, Christian W Kohler12, Peter Nürnberg9, Rex Au-Yeung13, Birgit Burkhardt14, Heike Horn15, Lorenzo Leoncini16, Elaine S Jaffe17, German Ott15, Grzegorz Rymkiewicz18, Matthias Schlesner3, Robert B Russell5, Wolfram Klapper13, Reiner Siebert1,2.
Abstract
The new recently described provisional lymphoma category Burkitt-like lymphoma with 11q aberration comprises cases similar to Burkitt lymphoma (BL) on morphological, immunophenotypic and gene-expression levels but lacking the IG-MYC translocation. They are characterized by a peculiar imbalance pattern on chromosome 11, but the landscape of mutations is not yet described. Thus, we investigated 15 MYC-negative Burkitt-like lymphoma with 11q aberration (mnBLL,11q,) cases by copy-number analysis and whole-exome sequencing. We refined the regions of 11q imbalance and identified the INO80 complex-associated gene NFRKB as a positional candidate in 11q24.3. Next to recurrent gains in 12q13.11-q24.32 and 7q34-qter as well as losses in 13q32.3-q34, we identified 47 genes recurrently affected by protein-changing mutations (each ≥3 of 15 cases). Strikingly, we did not detect recurrent mutations in genes of the ID3-TCF3 axis or the SWI/SNF complex that are frequently altered in BL, or in genes frequently mutated in germinal center-derived B-cell lymphomas like KMT2D or CREBBP An exception is GNA13, which was mutated in 7 of 15 cases. We conclude that the genomic landscape of mnBLL,11q, differs from that of BL both at the chromosomal and mutational levels. Our findings implicate that mnBLL,11q, is a lymphoma category distinct from BL at the molecular level.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30567752 PMCID: PMC6396176 DOI: 10.1182/blood-2018-07-864025
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113